First Time Loading...

RaySearch Laboratories AB (publ)
STO:RAY B

Watchlist Manager
RaySearch Laboratories AB (publ) Logo
RaySearch Laboratories AB (publ)
STO:RAY B
Watchlist
Price: 132.6 SEK 4.08% Market Closed
Updated: May 13, 2024
Section:
 

Relative Value

The Relative Value of one RAY B stock under the Base Case scenario is 205.15 SEK. Compared to the current market price of 132.6 SEK, RaySearch Laboratories AB (publ) is Undervalued by 35%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

RAY B Relative Value
Base Case
205.15 SEK
Undervaluation 35%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

4.4
P/S
P/S
Price to Sales
4.4
vs History
12
vs Industry
29
Median 3Y
3
Median 5Y
3.1
Industry
2.4
Forward
3.9
More Details
55.7
P/E
P/E
Price to Earnings
55.7
vs History
23
vs Industry
8
Median 3Y
-34.3
Median 5Y
-34.3
Industry
23.9
Forward
34.9
More Details
10
P/OCF
P/OCF
Price to OCF
10
vs History
4
vs Industry
36
Median 3Y
7.6
Median 5Y
7.6
Industry
15.6
More Details
23.9
P/FCFE
P/FCFE
Price to FCFE
23.9
vs History
9
vs Industry
22
Median 3Y
7.7
Median 5Y
7
Industry
22.5
More Details
6.2
P/B
P/B
Price to Book Value
6.2
vs History
7
vs Industry
12
Median 3Y
3.6
Median 5Y
4.1
Industry
2.3
More Details
4.5
EV/S
EV/S
Enterprise Value to Sales
4.5
vs History
9
vs Industry
28
Median 3Y
3.3
Median 5Y
3.3
Industry
2.5
Forward
4
More Details
5.1
EV/GP
EV/GP
Enterprise Value to Gross Profit
5.1
vs History
9
vs Industry
44
Median 3Y
3.6
Median 5Y
3.6
Industry
5.3
More Details
40.3
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
40.3
vs History
30
vs Industry
6
Median 3Y
27.7
Median 5Y
26.4
Industry
12.9
Forward
9.4
More Details
40.3
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
40.3
vs History
30
vs Industry
9
Median 3Y
27.7
Median 5Y
26.4
Industry
17.8
Forward
26.6
More Details
10.2
EV/OCF
EV/OCF
Enterprise Value to OCF
10.2
vs History
3
vs Industry
38
Median 3Y
8
Median 5Y
7.9
Industry
15.4
More Details
18.8
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
18.8
vs History
23
vs Industry
26
Median 3Y
9.7
Median 5Y
8.3
Industry
19.6
More Details
3
EV/IC
EV/IC
Enterprise Value to IC
3
vs History
15
vs Industry
27
Median 3Y
1.8
Median 5Y
2.3
Industry
2
More Details

Multiples Across Competitors

RAY B Competitors Multiples
RaySearch Laboratories AB (publ) Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
SE
RaySearch Laboratories AB (publ)
STO:RAY B
4.5B SEK 4.4 55.7 40.3 40.3
US
Veeva Systems Inc
NYSE:VEEV
32.9B USD 13.9 62.5 62.7 67.5
US
Cerner Corp
NASDAQ:CERN
27.9B USD 4.8 47.3 19.6 38.6
US
Change Healthcare Inc
NASDAQ:CHNG
9B USD 2.6 -116.8 16.5 111.6
AU
Pro Medicus Ltd
ASX:PME
11.8B AUD 81 169.8 116.8 116.8
JP
M3 Inc
TSE:2413
1.1T JPY 4.7 23.9 12.4 13.9
US
Inspire Medical Systems Inc
NYSE:INSP
4.8B USD 7.3 -306.7 -130.7 -119.4
US
Doximity Inc
NYSE:DOCS
4.3B USD 9.2 31.4 20.9 22.3
SE
Sectra AB
STO:SECT B
45.2B SEK 27.6 106.5 -70.1 -70.1
US
Vocera Communications Inc
NYSE:VCRA
2.8B USD 11.7 -324 264.4 4 233.4
US
Evolent Health Inc
NYSE:EVH
2.7B USD 1.4 -19.3 23.1 245.7
P/E Multiple
Earnings Growth
SE
RaySearch Laboratories AB (publ)
STO:RAY B
Average P/E: 71
55.7
162%
US
Veeva Systems Inc
NYSE:VEEV
62.5
139%
US
Cerner Corp
NASDAQ:CERN
47.3
N/A
US
Change Healthcare Inc
NASDAQ:CHNG
Negative Multiple: -116.8 N/A
AU
Pro Medicus Ltd
ASX:PME
169.8
119%
JP
M3 Inc
TSE:2413
23.9
26%
US
Inspire Medical Systems Inc
NYSE:INSP
Negative Multiple: -306.7 N/A
US
Doximity Inc
NYSE:DOCS
31.4
79%
SE
Sectra AB
STO:SECT B
106.5
56%
US
Vocera Communications Inc
NYSE:VCRA
Negative Multiple: -324 N/A
US
Evolent Health Inc
NYSE:EVH
Negative Multiple: -19.3 N/A

See Also

Summary
RAY B intrinsic value, competitors valuation, and company profile.
DCF Valuation
RAY B stock valuation using Discount Cash Flow valuation method.
Relative Valuation
RAY B stock valuation using valuation multiples.
Wall Street Estimates
RAY B price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
RAY B stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 136,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.